Cytiva published an application note evaluating two depth filter trains for clarification of a challenging CHO feed.
Published
Signal category
Research & Knowledge
Quote
“In this study, two depth filter trains were evaluated for clarification of a challenging CHO feed.”
— Kevin Dubs|Cytiva team
Company
Cytiva
We envision a world in which access to life-changing therapies transforms human health.
- Industry
- Biotechnology Research
- Location
- Global, OO
- Company size
- 9,958 employees
Cytiva, now with the life sciences business from Pall Corporation, is a global biotechnology leader dedicated to helping customers discover and commercialize the next generation of therapeutics. We bring dedicated technical expertise and a broad portfolio of tools, technologies, and services that enable the development, manufacture, and delivery of transformative medicines to patients. We're the provider of leading life science brands such as ÄKTA, Amersham, HyClone, MabSelect and Whatman. We are part of Danaher, a global science and technology leader. Along with other Danaher businesses, we accelerate the impact of tomorrow’s science and technology innovation to improve human health. Visit https://www.cytiva.com/privacy to review our privacy policy.